Also on the Welcome Sessions’ agendas was a presentation of Gene.iO, Genopole’s second phase of start-up accompaniment.

In this program, the laureate companies follow an intense course of coaching with the aim of successfully obtaining initial financing, a decisive step in a company’s maturation. The one-year Gene.iO program starts with a complete audit to identify the start-up’s needs and continues with coaching built around 4 Strategy Packs: Market Access, Fund Raising, Key Accounts Partnerships, and Communication Strategy.

In 2023, eight biotechs innovating in health or the bioeconomy were laureates of the third Gene.iO program. All were selected for the originality and pertinence of the technologies they are developing.

With the year’s new laureates, the number of start-ups accompanied by Gene.iO climbed to 22, of which 14 are Shaker graduates, 12 innovate in health and 10 in the bioeconomy. Since the launch of Gene.iO, 8 laureate companies have joined the campus and continue to develop their projects with the accompaniment of Genopole’s teams.

GENE.IO'S EIGHT LAUREATES IN 2023

IN HEALTH

Alga Biologics

Alga Biologics produces therapeutic antibodies through an innovative microalgae-based bioproduction system.

Alt Biotech (ex-laureate Shaker) has developed an innovative biomanufacturing method for cell-culture-accelerating recombinant proteins.

BioHive (ex-laureate Shaker) is a service provider proposing a novel in vitro skin model to realistically and reliably test new compounds of interest for the pharmaceutical and cosmetics industries.
 

Felome (ex-laureate Shaker) offers France’s first-ever service for pet DNA sequencing.

SE Therapeutics

SE Therapeutics (ex-laureate Shaker) has a patented method for easing the deployment of genetic tools, including CRISPR-Cas9, in a large range of cells.

Vitropep (ex-laureate Shaker) has invented soluble microneedle patches that enable effortless and pain-free delivery of therapeutic peptides with no resulting dangerous waste.

IN THE BIOECONOMY

AuraLip (ex-laureate Shaker) creates new, 100% natural proteins via the fermentation of hemp, with the goal of responding to the needs of meat alternatives manufacturers.

Fungu’it produces proteinaceous and functional ingredients via fungal solid-state fermentation while valorizing agricultural by-products.